Cytokinetics (NASDAQ:CYTK) Shares Gap Down Following Insider Selling
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report)’s stock price gapped down before the market opened on Monday following insider selling activity. The stock had previously closed at $51.86, but opened at $50.79. Cytokinetics shares last traded at $50.69, with a volume of 143,664 shares. Specifically, CEO Robert I. Blum sold 5,000 shares of the company’s […]
More Stories
Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Principal Financial Group Inc.
Principal Financial Group Inc. raised its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.3% in the 1st...
Calamos Advisors LLC Sells 8,240 Shares of Piper Sandler Companies (NYSE:PIPR)
Calamos Advisors LLC lessened its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 77.1% during the first quarter,...
Mutual Advisors LLC Trims Stock Position in iShares U.S. Aerospace & Defense ETF (BATS:ITA)
Mutual Advisors LLC cut its stake in shares of iShares U.S. Aerospace & Defense ETF (BATS:ITA – Free Report) by...
Principal Financial Group Inc. Sells 5,395 Shares of EMCOR Group, Inc. (NYSE:EME)
Principal Financial Group Inc. reduced its position in shares of EMCOR Group, Inc. (NYSE:EME – Free Report) by 4.7% in...
Principal Financial Group Inc. Buys 19,670 Shares of Discover Financial Services (NYSE:DFS)
Principal Financial Group Inc. grew its stake in shares of Discover Financial Services (NYSE:DFS – Free Report) by 6.7% in...
OPEC+ to Ramp Up Oil Output in August
By Jacob Burg The OPEC+ group of oil-producing countries said on July 5 that it would increase oil production by...